Tandem Diabetes Care: Q4 Earnings Insights
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell
• Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
Tandem Diabetes Care Announces FDA Clearance For t:slim X2 Insulin Pump To Bolus Using The t:connect Mobile App
First Smartphone App FDA cleared for Insulin Delivery on Both iOS and Android Operating Systems
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology
46 Biggest Movers From Yesterday
Gainers
Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.
36 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal emergency response systems to Federal, State and Local government purchasers.
Why Are Tandem Diabetes Shares Falling Premarket Today?
Tandem Diabetes Care Inc (NASDAQ:TNDM) reported Q3 sales of $179.6 million, +45% Y/Y, beating the consensus of $171.41 million. The…
SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $140
SVB Leerink analyst Danielle Antalffy maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Market Perform and raises the price target from $135 to $140.